Founder

Kemp Dolliver, CFA

Cherrystone Hill Research

Equity Capital Markets

China Resources Pharmaceutical Group / Equity Capital Markets

China Resources Pharmaceutical Group (3320 HK)

<p>China Resources Pharmaceutical is one of China’s leading integrated pharmaceuticals companies that manufactures, distributes, and retails prescription and OTC products. The company has filed an Application Proof with the HKEX. The financial press reports that the company intends to raise US$1 billion in an IPO this year, possibly as soon as this quarter.</p><p>This initial post will provide an overview and details of the manufacturing segment. The next post will discuss the balance of the business (distribution, retail, and R&amp;D pipeline). We will follow up with additional posts when the PHIP and other information are available.</p>

China Resources Pharmaceutical is one of China’s leading integrated pharmaceuticals companies that manufactures, distributes, and retails prescription and OTC products. The company has filed an Application Proof with the HKEX. The financial press reports that the company intends to raise US$1 billion in an IPO this year, possibly as soon as this quarter.This initial post will provide an overview and details of the manufacturing segment. The next post will discuss the balance of the business (distribution, retail, and R&amp;D pipeline). We will follow up with additional posts when the PHIP and other information are available.

China

China Resources Double-Crane Pharmaceutical Co., Ltd. develops, manufactures and markets a variety of medical products.  The Company's products include anti-influenza,  antihypertensives, and antibiotics.

China Resources Dubl Crne Phrmctl (600062 CH)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Resources Dubl Crne Phrmctl (600062 CH)

CR Pharma Listing: Part 1

China Resources Pharmaceutical is one of China’s leading integrated pharmaceuticals companies that manufactures, distributes, and retails...

Kemp Dolliver, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)